Viewing Study NCT06187142



Ignite Creation Date: 2024-05-06 @ 7:56 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06187142
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-02
First Post: 2023-12-16

Brief Title: Mobile Phone-Based Smoking-Cessation Intervention for Chronic Patients
Sponsor: Beijing Normal University
Organization: Beijing Normal University

Study Overview

Official Title: Mobile Phone-Based Smoking-Cessation Intervention for Chronic Patients a Sequential Multiple Assignment Randomized Trial SMART
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study aims to facilitate mobile phone-based cessation support for chronic patients using a sequential multiple assignment randomized trial SMART and combines different effective treatments to enhance engagement and determine the most effective adaptive interventions
Detailed Description: Noncommunicable diseases NCDs also known as chronic diseases affect of a large of number of people and cause 41 million death each year equivalent to 74 of globally mortality In China NCDs have caused 86 of deaths in the past three decades

Tobacco use is a type of modifiable behavioural risk factor for the development of noncommunicable disease and death It not only increases the risk of developing NCDs but also exacerbates their severity and complications Tobacco causes over 8 million deaths annually China has the worlds largest population of smokers more than 300 million Tobacco related deaths in China are 1 million per year Smoking cessation is one of the most effective and cost-efficient measures for the prevention and control of NCDs It can reduce the morbidity and mortality rates of NCDs and improve the health and quality of life of patients

Meanwhile among current smokers in China the prevalence of tobacco dependence was 497 smoking cessation services are extremely limited in China with only 366 clinics nationwide For smokers with NCDs hospitalization or outpatient treatment due to health problems can be a teachable moment for quit smoking Most physicians are unable to provide comprehensive cessation advice due to time and resource constraints and chronic patients face many relapse triggers after leaving the hospital Therefore it is necessary to implement staged and personalized smoking cessation interventions for chronic patients

To facilitate smoking cessation among chronic patients we propose to use a sequential multiple assignment randomized trial SMART design This adaptive approach is a concept of stepped treatment that aims to address the unmet needs of chronic patients and enhance smoking cessation outcomes

The study aims to facilitate mobile phone-based cessation support for chronic patients using a sequential multiple assignment randomized trial SMART and combines different effective treatments to enhance engagement and determine the most effective adaptive interventions

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None